While ICI could restore the function of exhausted virus‐specific CD8 T cells by PD‐1/PD‐L1 blockade, boosting immune control on HCC growth, it could also disrupt the immune homeostasis in the liver, leading to an increased immune response to hepatocytes and subsequent liver damage. The gene discussed is CD274; the disease is hepatocellular carcinoma.